Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Glaucoma Surgery Using the ViaLase Laser System [NA]
Clinical trial update for glaucoma surgery using the ViaLase laser system; the study is completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study [Phase 3]
A Phase III study comparing DE-117 ophthalmic solution to timolol for glaucoma or ocular hypertension completed with posted results.
-
FDA approval · 2023-08-25FDA Approved: ACETAZOLAMIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for acetazolamide sodium filed by Mylan Institutional LLC, approving the salt form of acetazolamide …
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Agreement and Precision Study of the Nidek Mirante [NA]
Clinical trial update for Nidek Mirante study indicating completion and posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Use of Bevacizumab in Trabeculectomy Surgery [Phase 4]
Phase 4 trial updates the use of bevacizumab as an adjunct in trabeculectomy surgery for glaucoma, with results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-16FDA Approved: ACETAZOLAMIDE — Supplemental Application (TRUPHARMA, LLC)
FDA approved a supplemental application for acetazolamide from TRUPHARMA, LLC under ANDA 211372. This action updates the approval status of …
-
FDA approval · 2023-08-16FDA Approved: ACETAZOLAMIDE — Supplemental Application (Eywa Pharma Inc)
The FDA approved Eywa Pharma Inc's supplemental application for acetazolamide, enabling continued marketing of a generic acetazolamide produ…
-
FDA approval · 2023-08-09FDA Approved: ACETAZOLAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' supplemental application for acetazolamide, finalizing approval for changes to the approved generic produc…
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study [Phase 3]
Phase III study comparing DE-117 ophthalmic solution to timolol for glaucoma or ocular hypertension; trial completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution [Phase 2]
Phase 2 trial evaluating travoprost intraocular implants versus timolol solution for open-angle glaucoma has completed with results posted.
-
FDA approval · 2023-07-28FDA Approved: BRINZOLAMIDE — Original Application (Padagis US LLC)
FDA approved the original ANDA for brinzolamide from Padagis US LLC, authorizing a generic brinzolamide product.
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients. [Phase 3]
A Phase 3 trial comparing T4030 Eye Drops with Ganfort in patients with ocular hypertension or glaucoma has completed, assessing efficacy an…
-
FDA approval · 2023-06-22FDA Approved: LEVOBUNOLOL HYDROCHLORIDE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for levobunolol hydrochloride (generic beta-blocker) from Bausch & Lomb Incorporated.
-
FDA approval · 2023-06-02FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application to authorize a preservative-free version of dorzolamide hydrochloride and timolol maleate eye drops …
-
FDA approval · 2023-05-26FDA Approved: TIMOLOL MALEATE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original ANDA for Timolol Maleate Ophthalmic, a generic eye drop used to lower intraocular pressure in…
-
FDA approval · 2023-05-24FDA Approved: ACETAZOLAMIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for acetazolamide submitted by Chartwell RX, LLC.
-
FDA approval · 2023-05-19FDA Approved: ACETAZOLAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Acetazolamide from Accord Healthcare Inc., a generic drug.
-
CLINICAL_TRIALS trial_result · 2023-05-17Clinical Trial Update: Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma [Phase 3]
Phase 3 trial update on the safety and effectiveness of the XEN45 Glaucoma Treatment System in angle-closure glaucoma.
-
FDA approval · 2023-05-09FDA Approved: ACETAZOLAMIDE — Original Application (Marlex Pharmaceuticals, Inc.)
FDA approved acetazolamide as an original ANDA from Marlex Pharmaceuticals, providing a generic version of the carbonic anhydrase inhibitor.…
-
FDA approval · 2023-04-26FDA Approved: LATANOPROST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for LATANOPROST from Sandoz Inc (AP), marking regulatory approval for this generic glaucoma therapy.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 [Phase 2]
Phase 2 trial update on GL101 aiming to reduce adverse ocular side effects from glaucoma medications in glaucoma patients.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 trial comparing Perrigo's product to FDA-approved treatment for glaucoma or ocular hypertension has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications [NA]
A completed clinical trial evaluating a universal eye drop adherence monitor to measure and improve adherence to ocular medications, includi…
-
FDA approval · 2023-01-23FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for dorzolamide hydrochloride (generic) submitted by Sandoz Inc to support its use as an ophthalmic …
-
FDA approval · 2023-01-23FDA Approved: ACETAZOLAMIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for Acetazolamide (generic) submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals In…